Anti-cholinergic effect of singulair on isolated rat's tracheal smooth muscle

Li Hsiang Cheng, Chuan Hsiang Kao, Chih Hung Wang, Yueng Hsiang Chu, Jia Yi Wang, Hsing Won Wang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Singulair (Montelukast) is a potent and selective leukotriene D4 receptor antagonist, often used in treating inflammatory conditions of the respiratory system such as allergic rhinitis and asthma. However, the eVects of singulair given intratracheally have rarely been well explored. To verify the eVect of singulair, which acts on the tracheal smooth muscle directly in vitro. We used our preparation to test the eVects of singulair on isolated rat's tracheal smooth muscle. The following assessments of singulair were performed: (1) effect on the tracheal smooth muscle resting tension, (2) eVect on contraction caused by 10-6 M methacholine as a parasympathetic mimetic, and (3) eVect of the drugs on electrically induced tracheal smooth muscle contractions. The results indicated that the addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of singulair at doses of 10-5 M or above elicited a signiWcant relaxation response to 10-6 M methacholine-induced contraction Singulair could not inhibit electrical Weld stimulationinduced spike contraction. It also had a minimal eVect on the basal tension of trachea as the concentration increased. This study showed that the high concentrations of singulair also had an anti-cholinergic eVect for relieving symptoms of asthma.

Original languageEnglish
Pages (from-to)1923-1927
Number of pages5
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume269
Issue number8
DOIs
Publication statusPublished - Aug 2012

Fingerprint

montelukast
Cholinergic Antagonists
Cholinergic Agents
Smooth Muscle
Methacholine Chloride
Trachea
Asthma
Leukotriene Antagonists
Muscle Tonus

Keywords

  • In vitro study
  • Singulair
  • Tracheal smooth muscle

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Anti-cholinergic effect of singulair on isolated rat's tracheal smooth muscle. / Cheng, Li Hsiang; Kao, Chuan Hsiang; Wang, Chih Hung; Chu, Yueng Hsiang; Wang, Jia Yi; Wang, Hsing Won.

In: European Archives of Oto-Rhino-Laryngology, Vol. 269, No. 8, 08.2012, p. 1923-1927.

Research output: Contribution to journalArticle

Cheng, Li Hsiang ; Kao, Chuan Hsiang ; Wang, Chih Hung ; Chu, Yueng Hsiang ; Wang, Jia Yi ; Wang, Hsing Won. / Anti-cholinergic effect of singulair on isolated rat's tracheal smooth muscle. In: European Archives of Oto-Rhino-Laryngology. 2012 ; Vol. 269, No. 8. pp. 1923-1927.
@article{ff1330f3b483461982bd4bbf083b490e,
title = "Anti-cholinergic effect of singulair on isolated rat's tracheal smooth muscle",
abstract = "Singulair (Montelukast) is a potent and selective leukotriene D4 receptor antagonist, often used in treating inflammatory conditions of the respiratory system such as allergic rhinitis and asthma. However, the eVects of singulair given intratracheally have rarely been well explored. To verify the eVect of singulair, which acts on the tracheal smooth muscle directly in vitro. We used our preparation to test the eVects of singulair on isolated rat's tracheal smooth muscle. The following assessments of singulair were performed: (1) effect on the tracheal smooth muscle resting tension, (2) eVect on contraction caused by 10-6 M methacholine as a parasympathetic mimetic, and (3) eVect of the drugs on electrically induced tracheal smooth muscle contractions. The results indicated that the addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of singulair at doses of 10-5 M or above elicited a signiWcant relaxation response to 10-6 M methacholine-induced contraction Singulair could not inhibit electrical Weld stimulationinduced spike contraction. It also had a minimal eVect on the basal tension of trachea as the concentration increased. This study showed that the high concentrations of singulair also had an anti-cholinergic eVect for relieving symptoms of asthma.",
keywords = "In vitro study, Singulair, Tracheal smooth muscle",
author = "Cheng, {Li Hsiang} and Kao, {Chuan Hsiang} and Wang, {Chih Hung} and Chu, {Yueng Hsiang} and Wang, {Jia Yi} and Wang, {Hsing Won}",
year = "2012",
month = "8",
doi = "10.1007/s00405-011-1880-8",
language = "English",
volume = "269",
pages = "1923--1927",
journal = "European Archives of Oto-Rhino-Laryngology",
issn = "0937-4477",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Anti-cholinergic effect of singulair on isolated rat's tracheal smooth muscle

AU - Cheng, Li Hsiang

AU - Kao, Chuan Hsiang

AU - Wang, Chih Hung

AU - Chu, Yueng Hsiang

AU - Wang, Jia Yi

AU - Wang, Hsing Won

PY - 2012/8

Y1 - 2012/8

N2 - Singulair (Montelukast) is a potent and selective leukotriene D4 receptor antagonist, often used in treating inflammatory conditions of the respiratory system such as allergic rhinitis and asthma. However, the eVects of singulair given intratracheally have rarely been well explored. To verify the eVect of singulair, which acts on the tracheal smooth muscle directly in vitro. We used our preparation to test the eVects of singulair on isolated rat's tracheal smooth muscle. The following assessments of singulair were performed: (1) effect on the tracheal smooth muscle resting tension, (2) eVect on contraction caused by 10-6 M methacholine as a parasympathetic mimetic, and (3) eVect of the drugs on electrically induced tracheal smooth muscle contractions. The results indicated that the addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of singulair at doses of 10-5 M or above elicited a signiWcant relaxation response to 10-6 M methacholine-induced contraction Singulair could not inhibit electrical Weld stimulationinduced spike contraction. It also had a minimal eVect on the basal tension of trachea as the concentration increased. This study showed that the high concentrations of singulair also had an anti-cholinergic eVect for relieving symptoms of asthma.

AB - Singulair (Montelukast) is a potent and selective leukotriene D4 receptor antagonist, often used in treating inflammatory conditions of the respiratory system such as allergic rhinitis and asthma. However, the eVects of singulair given intratracheally have rarely been well explored. To verify the eVect of singulair, which acts on the tracheal smooth muscle directly in vitro. We used our preparation to test the eVects of singulair on isolated rat's tracheal smooth muscle. The following assessments of singulair were performed: (1) effect on the tracheal smooth muscle resting tension, (2) eVect on contraction caused by 10-6 M methacholine as a parasympathetic mimetic, and (3) eVect of the drugs on electrically induced tracheal smooth muscle contractions. The results indicated that the addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of singulair at doses of 10-5 M or above elicited a signiWcant relaxation response to 10-6 M methacholine-induced contraction Singulair could not inhibit electrical Weld stimulationinduced spike contraction. It also had a minimal eVect on the basal tension of trachea as the concentration increased. This study showed that the high concentrations of singulair also had an anti-cholinergic eVect for relieving symptoms of asthma.

KW - In vitro study

KW - Singulair

KW - Tracheal smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=84864991312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864991312&partnerID=8YFLogxK

U2 - 10.1007/s00405-011-1880-8

DO - 10.1007/s00405-011-1880-8

M3 - Article

C2 - 22203119

AN - SCOPUS:84864991312

VL - 269

SP - 1923

EP - 1927

JO - European Archives of Oto-Rhino-Laryngology

JF - European Archives of Oto-Rhino-Laryngology

SN - 0937-4477

IS - 8

ER -